Coldpine

PAYX Congressional Stock Trades

PAYCHEX, INC. CMN

Last disclosed trade Jun 1

Every disclosed trade in PAYX by members of Congress under the STOCK Act, parsed by Coldpine. Informational only, sourced from public filings. Not investment advice.

Coldpine’s read

The one-day disclosure lag is unusually fast, indicating a recent and potentially actionable purchase. Paychex sits outside Greene's typical committee-aligned trades, suggesting a portfolio diversification rather than sector-specific positioning. No other members traded PAYX in the same window, so this is an isolated rather than cluster move.

Marjorie Taylor Greene · Bought · Nov 12

Coldpine scores and writes a rationale for every congressional trade. See the full scored analysis with Pro →

Follow $PAYX

Get notified when any member of Congress trades $PAYX. Free, no card, no spam.

Follow free →
52
Disclosed trades
34
Buys
18
Sells
9
Members trading

Members who trade PAYX

Recent disclosed trades in PAYX

DateMemberTypeAmount
Jun 1Michael T. McCaul(TX)buy$100K–$250K
May 20Michael T. McCaul(TX)buy$15K–$50K
May 12Michael T. McCaul(TX)buy$100K–$250K
Apr 24Rohit Khanna(CA)sell$1K–$15K
Apr 21April McClain Delaney(MD)sell$1K–$15K
Apr 16April McClain Delaney(MD)sell$1K–$15K
Apr 13Rohit Khanna(CA)buy$1K–$15K
Apr 7Rick Larsen(WA)sell$1K–$15K
Mar 4Michael T. McCaul(TX)buy$100K–$250K
Feb 24April McClain Delaney(MD)sell$1K–$15K
Feb 23April McClain Delaney(MD)sell$1K–$15K
Feb 20Shelley M Capito(WV)sell$1K–$15K
Jan 14Richard W. Allen(GA)sell$15K–$50K
Dec 12Rohit Khanna(CA)buy$1K–$15K
Dec 5Rohit Khanna(CA)buy$1K–$15K
Nov 12Marjorie Taylor Greene(GA)buy$15K–$50K
Nov 10Rohit Khanna(CA)sell$1K–$15K
Nov 3Rohit Khanna(CA)sell$1K–$15K
Oct 7Rohit Khanna(CA)buy$1K–$15K
Oct 1April McClain Delaney(MD)buy$1K–$15K

Showing 20 of 52 disclosed trades.

Sign up free for the full history, signal scores, and price-vs-trades chart. Pro adds Coldpine's read — the AI narrative on each trade.

Create a free account

Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores — free with an account →